On April 10, 2024, Universal Ibogaine Inc. closed the transaction. The company issued 57,557,600 common shares at a issue price of CAD 0.01 per share for gross proceeds of CAD 575,576. The securities issued in connection with the Offering will be subject to a four-month hold period.

On April 17, 2024, the company announced that the TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement. The transaction included participation from 16 placees.